6 completed, 2 active not recruiting, 1 withdrawn. 9 Phase 2, 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 6, Active not recruiting 2, Withdrawn 1 |
| Phase 1 | 4 | Active not recruiting 2, Completed 2 |
Follow InSightec: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
Breast Neoplasms (3) · Glioblastoma (3) · Brain Neoplasms (2) · Bone Neoplasms (1) · Cancer Pain (1) · Disease (1) · Low Back Pain (1) · Lung Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Pain (1) · Prostatic Neoplasms (1)
Carboplatin (2) · Doxorubicin (2) · High-Intensity Focused Ultrasound Ablation (1) · pembrolizumab (1)
United States (4) · Canada (3) · Israel (2) · Germany (1) · Italy (1) · South Korea (1) · United Kingdom (1)
Hans Kolberg, MD (1) · Robert W. Newman (1) · Sagi Harnof, MD (1) · Vinay Puduvalli, MD (1)